ZARR — Dashboard

Eli Lilly's blowout quarter

The biggest single story in the feed is Eli Lilly. Q3 2026 adjusted EPS came in at $7.48 against consensus of roughly $5.60 to $6.26, on revenue of $24.4 billion, up 39% year over year and about $1.8 billion ahead of estimates. Management raised full-year 2026 revenue guidance to $91-92 billion from $85-87 billion, versus a Street figure near $88.7 billion. Mounjaro did $10.72 billion and Zepbound $5.35 billion, both above estimates, with the new oral weight-loss pill Foundayo adding $184 million. CEO David Ricks put it down to broad global demand for the two tirzepatide drugs plus a doubling in newer oncology, immunology and neuroscience products. The night before, Lilly released Phase 3 TRANSCEND-T2D-2 data showing retatrutide delivered more than double the weight loss of Novo Nordisk's highest approved Ozempic dose in type 2 diabetics, which had already lifted the shares after hours. The stock was up 4.5% pre-open at $1,346.50, above its prior 52-week high of $1,321.21, against a soft tape. Barclays recently went to a $1,400 target; RBC and Morgan Stanley hold Overweight-equivalent ratings. A separate Investor's Business Daily headline covers the same beat-and-raise.

Carrier beat but sold off hard

Carrier Global is the mirror image. Adjusted EPS of $0.87 on $6.26 billion of revenue beat forecasts of $0.77 and $6.10 billion, organic sales grew 15%, adjusted operating profit about 35%, and margin expanded 260 basis points. Data center orders rose 300% in the quarter, with year-to-date data center orders above $3 billion and segment sales over $550 million. Even so the stock was indicated down 7.89% premarket at $51.83, near its 52-week low of $50.24. The reason given: Carrier raised its full-year sales outlook to nearly $24 billion but left adjusted EPS guidance unchanged at $2.85-2.90, cut the CSA segment margin outlook to roughly 19%, and flagged residential pricing realization coming in below plan. Year-to-date input cost headwinds run about $800 million, slightly under half tariff-related, with $550-600 million of that unexpected. CEO David Gitlin conceded the company was "chasing pricing a little bit" this year and has announced increases up to 10% across CSA, including 8% on residential late in Q4. A companion slides item covers the same quarter.

Textron and West Pharmaceutical raised guidance

Two clear beat-and-raise industrials. Textron earned $1.76 adjusted on $3.8 billion against $1.43 and $3.77 billion expected, lifted full-year EPS guidance to $6.55-6.65 and manufacturing cash flow to $800-900 million, mostly on roughly $100 million less capex. Aviation revenue rose 14% to $1.7 billion with the highest order bookings in nearly three years, Systems rose 16%, but Bell fell 9% to $933 million and the MV-75 low-rate production award has slipped into 2027, widening the expected charge range to $110-150 million from $60-110 million. Shares were up 4.72% at $82.02 premarket. West Pharmaceutical posted $2.66 adjusted EPS on $874.5 million, versus $2.20 and $827.1 million, with gross margin up 310 basis points to 39.7%. HVP Components grew 20% organically to $467 million on GLP-1 and biologics demand plus containment-rule upgrade projects, and Asia Pacific revenue rose 42%. Full-year guidance went to $3.41-3.42 billion of revenue and $9.38-9.48 EPS. The stock was up 4.8% at $423 premarket, just above its prior 52-week high.

Smaller beats with mixed reactions

Garrett Motion beat on profit, $0.51 against $0.47, and missed slightly on revenue at $930 million versus $940.71 million. Adjusted EBIT margin rose 160 basis points to 16.3%, free cash flow was $136 million, and commercial vehicle and industrial sales grew 23% organically. It lifted its 2027 industrial sales outlook to roughly $300 million, mostly genset power generation, and approved a new $250 million buyback. Shares were up 4.69% at $23.377. Silgan earned $1.31 against $1.25 but revenue of $2.04 billion missed the $2.10 billion estimate; it raised full-year EPS guidance to $3.83-3.93 and reaffirmed about $450 million of free cash flow, helped by fragrance and beauty, prescription pharma dispensing and wet pet food, with soup demand weaker than expected. Stock up 4.35% at $39.58. Proto Labs beat on both lines, $0.63 on $154.3 million of record revenue, and raised full-year growth guidance to 10-11%, but fell 3.2% premarket to $88 as gross margin slipped 140 basis points to 44.5% on raw material costs and machine upgrades, and Q4 EPS guidance of $0.46-0.54 sits below Q3. AXIS Capital missed on EPS at $2.75 versus $2.85 despite revenue of $1.79 billion beating $1.69 billion; the combined ratio widened to 94.0% from 89.4% on $75 million of catastrophe and war losses against $44 million a year ago, and shares fell 4.54% to $97.

Filler 8-K items with no content

Six of the full-text reads turned out to be empty Form 8-K stubs from Investing.com, for Catalyst Bancorp, Sidus Space, 374Water, bioAffinity, InterDigital and Azitra. The pages contain no filing detail at all beyond the ticker and a tick in the article header, so there is nothing to report from them.

Headline-only earnings and macro

The bulk of the remaining 180-odd items are headlines. On earnings, Cognizant is reported down 10% premarket on a weak Q4 outlook, Fortinet is referenced after a 25% post-earnings selloff, ServiceNow fell after its print, Bristol Myers slipped on short Opdivo sales and a cut to earnings guidance, and Norwegian Cruise Line is described as soaring on a beat-and-raise. Alphabet gets two angles: a headline that shares tumbled 10% as a search slowdown overshadowed cloud strength, and a TradingView piece asking why the stock is selling off despite AI growth. Others reporting include Hippo (beat, raised guidance), Bunge, LKQ, Everest Group, Ranpak, Axalta, CRH, Cimpress, T. Rowe Price, Republic Airways, Coastal Financial, Pitney Bowes, NovoCure, Cogeco and a batch of Indian names. On macro, US initial jobless claims came in at 194K, described as beating expectations and near 57-year lows, and Q3 GDP growth is reported as accelerating and above forecasts. A widely-quoted post has the euro falling 0.4% to $1.11095, its lowest since May 2025.

Analyst notes and corporate actions

There is a visible Stephens cluster: target raises on Regional Management, Prosperity Bancshares, First Interstate BancSystem and Kirby, a cut on PROG Holdings over leasing concerns, and a C.H. Robinson target lowered to $190 on claims costs. Elsewhere Needham raised Q2 Holdings to $85, Argus upgraded Biogen on rare disease strength, Truist reiterated Buy on Clean Harbors with a $365 target, and Deutsche Bank initiated positively on TK Accelis. On deals and capital, Thrive Holdings is reported acquiring ADT for $7.6 billion in cash, Ambev approved a buyback of up to 190 million common shares, FTAI Aviation announced a $500 million accelerated repurchase, Freedom Holding's subsidiary entered a $1.16 billion bond investment agreement, BioMarin licensed a Fabry disease therapy for $70 million upfront, Eightco sold its OpenAI stake at a 40% gain, and Kalshi is reported at a $40 billion valuation after a $1 billion round co-led by Wellington and Sequoia. UBS reported 3Q26 net profit of 2.7 billion.

Geopolitics, commodities and chart posts

A sizeable tail of the feed is technical-analysis posts on TradingView covering gold, bitcoin, EURUSD, USDJPY, the Nikkei, Hang Seng, DAX and various crypto pairs, none of which carry reported news. On the geopolitical side, headlines reference an Iran war adding $11 billion a month to the EU's oil import bill, Air France suspending Riyadh flights to December 12 and Dubai flights to November 7, and a Kremlin aide warning that Ukrainian attacks during November 4 celebrations could affect Russia's stance on trilateral talks. Javier Blas notes US retail gasoline prices are down more than 5% over the past month even as oil has risen. One further item says Nvidia CEO Jensen Huang has been caught up in a reported Chinese spy probe as AI stocks slide.

Microsoft's Azure quarter

The biggest piece of real substance in the feed is Microsoft's fiscal Q1 2027, covered in full. Revenue came in at $92.3 billion, up 19% year over year against consensus near $90.7 billion, and adjusted EPS of $4.89 beat the $4.72 expected. Azure was the standout: up 48% to $33.2 billion, ahead of the company's own 44%–45% guidance and up from $29.4 billion the prior quarter. Commercial backlog reached $677 billion, up 73%. The article notes Microsoft stayed cash-flow positive even with capex roughly doubling, which speaks directly to the AI-spending-discipline worry that had been hanging over Big Tech since Meta's results. The stock rose 4.5% after hours to $554.68, above its prior 52-week high of $551.15. The Nasdaq had closed the regular session down 0.6% ahead of the Fed decision on October 29, with rates widely expected to hold at 3.75%–4.00%.

Alphabet misses on earnings, cloud booms

Alphabet is the mirror image and it's covered from several angles here. The earnings item reports Q3 EPS of $2.12 against a $3.02 estimate, a $0.90 miss, on revenue of $127.6 billion versus $127.22 billion expected. Headlines around it say shares fell 7% after hours despite the cloud number, with separate posts breaking out Google Cloud revenue up 102.6% to $30.7 billion and operating income up 209.4% to $11.1 billion, Search up 12% to $63.4 billion, YouTube ads up 9.2%, and Alphabet raising roughly $41.1 billion in the quarter through $28.7 billion of senior unsecured notes and $12.4 billion of at-the-market equity. Another headline flags heavier-than-expected cash burn from cloud spending. So the two megacaps reporting the same evening were judged on the same question, AI capex versus returns, and landed on opposite sides.

Bausch Health earnings and balance sheet

Bausch Health rose 11.5% after hours on Q3 2026 results. Adjusted EPS was $1.77 against consensus near $1.27, revenue $2.94 billion against $2.72–$2.75 billion expected and up roughly 10% year on year. Management raised full-year revenue guidance to $10.975–$11.175 billion and lifted the adjusted EBITDA outlook. The board also authorised a $50 million buyback starting early November, aimed at offsetting dilution from employee equity, and the company said it will fully redeem about $643 million of 8.500% senior notes due 2027 from cash on hand, with a November 30 redemption date. The article is explicit that the broader tape gave no help, with the S&P 500 off 0.3% and the Nasdaq down 1.0%, so the move was all company news.

Earnings headlines beyond the full reads

A long list of results sits here as headlines only, with no detail beyond what each line states. Beats: Ford (by $0.08, revenue topped, with other headlines saying it raised guidance and shares edged lower), T-Mobile (by $0.33, plus a raised annual free cash flow forecast), Gen Digital, Align, MYR Group (by $0.83), Sterling Infrastructure (by $1.38), Everspin, Origin Bancorp, Regional Management, Alerus Financial, McGrath, Cohu (on AI demand), Flowserve, and Glaukos, said to be up 13% on the beat and raised guidance. Misses and weak reactions: Everest by $0.53 with revenue short, ServiceNow down 16% after hours, Fortinet with revenue growth described as underwhelming, Align down 5% on a weak Q4 revenue outlook despite the beat, and Sprouts Farmers Market down 15% on guidance and a Q3 miss. Also here: eBay up on Q3, Chipotle beating on sales, FedEx raising its outlook, Honeywell Aerospace lifting its second-half free cash forecast, Stellantis reporting €37.6 billion of net revenues, and Infosys at $5,145 million with $5.2 billion of large deal TCV.

Fed, macro and geopolitics

Headlines carry the Fed holding rates steady as expected with two policymakers preferring a 25bp hike, and Wall Street ending slightly higher after it. Bessent soundbites cover an energy supply shock and a wish for the Fed to keep an open mind, confidence in Warsh, and an expectation of a strong Q3 GDP print. Separately, Vance has reportedly written to Iran's top security official to restart talks ahead of possible US strikes after the midterms, per the WSJ lines in the feed. Commodity headlines: cocoa lower on rising ICE inventories and possible Brazilian sales, sugar higher on reduced Brazilian milling, coffee at a two-week low on a weaker real and arriving beans, nat gas up on cooler forecasts and restored LNG shipments.

Corporate actions and analyst notes

Smaller items with real content: Markel entered a $2.3 billion reinsurance deal with Enstar, Amrize completed a $1 billion buyback, Radian named Daniel Kobell CFO, Q2 Holdings appointed Jonathan Price co-CEO and reported Q3 revenue of $225.8 million with raised guidance, Rio Tinto is adding lithium plants in Argentina, and SPACCircle Acquisition closed a $100 million Nasdaq IPO. Analyst moves, all headline-only: Oppenheimer raised its Masco target on earnings growth, Stifel took GE HealthCare to $90 on a strong Q3, Mizuho raised AxoGen to $65, Jefferies raised Etsy to $100, and Freedom Broker upgraded Royal Caribbean on Q3 results. Routine dividends from PVH, IFF, Black Hills and Hennessy Advisors.

The rest is filing noise

A large share of the 200 items is boilerplate. Ten of the twenty full reads were Form 8-K stub pages from Investing.com for Axis Capital, Q2 Holdings, SEACOR Marine, KLA, Universal Display, Pitney Bowes, CONMED, Houlihan Lokey, Morningstar, Impinj, UFP Industries and ABM, and they contain nothing beyond the ticker and the filing date. Add to that a run of Nasdaq screener outputs on oversold ETFs and moving-average crosses, a batch of TradingView chart posts on bitcoin, ETH, gold and FX pairs, and assorted insider Form 4s. Nothing in that group carries information worth your time.

AxoGen jumps on beat and raised guidance

The biggest mover in the full-read items is AxoGen, up 20.53% in premarket trading to $45.15 from $37.46. Third-quarter adjusted EPS came in at $0.21 against a $0.13 estimate, with revenue of $75.8 million versus $73.16 million expected, up 26.2% from a year earlier. Breast reconstruction was the fastest-growing piece, with revenue in that segment up more than 60%, and Avance Nerve Graft made up 64% of revenue. Management raised full-year guidance to at least $290 million, or growth of at least 29%, with $283 million organic. The recently acquired BioCircuit brings NerveTape and should add at least $7 million in the fourth quarter and roughly $34 million in 2027 net of cannibalisation. Commercial payer coverage for Avance now reaches about 96% of US covered lives. Gross margin was 74.8%, down 180 basis points year on year on higher product costs but up sequentially from 72.7%.

Evercore's record quarter

Evercore rose 9.55% premarket to $284.68. Adjusted EPS of $4.28 beat the $2.53 estimate by 69%, and revenue of $1.17 billion came in 33% above the $878 million forecast. Adjusted net revenues were up 13% year on year at roughly $1.2 billion, a sixth consecutive quarterly record, with advisory fees of $1 billion. The compensation ratio fell to 63% from 65%, and the firm returned $189 million in the quarter, over $1 billion year to date. CEO John Weinberg pointed to record backlogs replenishing at a healthy rate; management also said non-M&A businesses now account for more than 40% of firmwide adjusted net revenues over the last four quarters. Note the stock had fallen 23% over the prior six months.

Beat-but-sold cluster: Blackbaud, V.F., Chefs' Warehouse

Three companies beat and still fell premarket, which is the clearest pattern in today's full reads. Blackbaud dropped 8.75% to $49 despite non-GAAP EPS of $1.36 against $1.33, because revenue of $292.64 million was essentially dead on the estimate; growth was 4.1%, free cash flow was $126 million, and the 2026 renewal cohort is about 40% larger than 2025's, which management said is weighing on reported growth into early 2027. V.F. Corp fell 3.82% to $16.38 after EPS of $0.70 against $0.53 and revenue of $2.7 billion against $2.66 billion, with gross margin up 290bp to 55.4%; Vans still fell 9.8% in the quarter and the company flagged $70 million to $80 million of unmitigated tariff costs in the second half. The Chefs' Warehouse fell 3.66% to $105 after EPS of $0.66 versus $0.58 and sales up 11.2% to $1.135 billion, with adjusted EBITDA up 26.3% and full-year guidance raised to $4.56–$4.61 billion in sales; the article notes the stock is up 86% over the past year on a P/E above 51.

GE Vernova orders and the Trench deal

GE Vernova beat on both lines, EPS $4.81 against $4.00 and revenue $12.64 billion against $12 billion, but shares rose only 0.55% premarket to $900. Orders nearly doubled, up 96% to $29.3 billion with book-to-bill above 2.0x, and backlog grew from $176 billion to about $200 billion. Free cash flow was $5.4 billion, up $4.7 billion year on year. Full-year guidance went up to $46.5–$47.5 billion revenue, 13.5–14.5% adjusted EBITDA margin and $16–$17 billion free cash flow, with Power margins hitting 21.4%. The company announced the Trench Group acquisition for its high-voltage grid business and doubled its buyback to $20 billion. Wind remains the soft spot. A separate headline-only slide deck item puts the Trench price at $9 billion.

European and Indian names

KPIT Technologies rose 3.87% to 552.5 on a quarter management called in line: revenue up 6.5% in rupee terms but roughly flat in constant currency, EBITDA margin up 60bp to 17.8%, product revenue up 25%, off-highway and commercial vehicles up 27%, passenger cars down 7%. Two large customers cutting or cancelling programmes cost the equivalent of 13% of sales, and margins are not expected back to 20–21% until early FY2028. KPN gained 2.87% to $4.199 on revenue of $1.5 billion against $1.47 billion expected, with group service revenue up 2.7% and EPS exactly in line; it reaffirmed its dividend and the EUR 250 million buyback. Epiroc went the other way, down 2.6% to $209.8 even with orders up 12% organically to SEK 17.5 billion and adjusted margin up to 20.4%, as operating cash flow fell to SEK 1.4 billion from SEK 2.5 billion on inventory build and long equipment lead times delay revenue conversion.

Smaller financials

OceanFirst posted core EPS of $0.48 against $0.40 and revenue of $185.13 million against $177.79 million in its first full quarter with Flushing Financial; net interest income rose to $172 million and core expenses of $114 million came in under the $120–125 million guide, though GAAP EPS was just $0.17 after $0.30 of merger costs. The stock barely moved. John Marshall Bancorp earned $0.55 against a $0.50 estimate on revenue of $18.06 million versus $18.61 million expected. HBT Financial declared a quarterly dividend of $0.25, payable 17 November to holders of record 9 November; the article notes the stock is up 55% over the past year near its 52-week high, and recent target raises from Keefe Bruyette & Woods to $43 and DA Davidson to $38.

What the headline-only items flag

A lot of this feed is routine Form 8K filings with no content behind them, plus a wall of TradingView chart posts. The headlines worth knowing about, without more detail than the headline gives: Boston Scientific fell 11% with a cybersecurity attack cited as weighing on guidance, Dropbox is cutting about 9% of its workforce with its CTO departing, LCI Industries confirmed an unsolicited non-binding $101-per-share cash proposal from Monomoy Capital Partners, and Artiva halted a cell therapy after patient deaths and cut 94% of staff. Robinhood fell on a Q3 miss with analyst target cuts, GSK dropped on weaker vaccine sales, and Sandoz cut its sales outlook. On earnings still to land, Alphabet and Microsoft report and the Fed decision is due. In the UK, Healey delivered his first budget, cutting the 2027 growth forecast to 1% and fiscal headroom to about £15 billion. Elsewhere: SK Hynix shares surged on a profit beat, Stellantis beat on revenue, EQT is acquiring Range, IREN secured $363 million of equipment financing, Scripps raised its political ad outlook while cutting 850 jobs, and the US goods trade deficit widened unexpectedly to $134.9 billion.

Visa beats but guides lower

The one piece of real depth in the feed is Visa's fiscal Q4. Adjusted EPS came in at $3.48 against a $3.44 consensus, and net revenue of $12.1 billion, up 13% year over year, matched expectations. The stock still fell 2.3% after hours, to $392.73 from a regular-session high of $403.51, because fiscal 2027 guidance calls for EPS growth in the low double digits to low teens, down from the 16% delivered in fiscal 2026. Payment volume growth also ticked down versus the prior quarter. Baird had flagged before the print that trimmed FY27 estimates could pressure a stock trading above its five-year average multiple; Susquehanna had gone the other way, lifting its target to $480 on Visa's positioning for agentic AI commerce. The board raised the quarterly dividend to $0.780. The article also notes two regulatory items sitting in the background: a potential £5 billion UK interchange lawsuit covering Visa and Mastercard, and lower small-merchant interchange rates that took effect in October 2026. Separately in the feed, headline-only posts quote Visa's CEO calling it "a milestone year" with record net revenue of $46 billion, up 15%.

After-hours earnings reactions

A large cluster of headline-only items covers the post-close tape. On the downside: CoStar down 12% despite topping Q3 estimates, Enphase down more than 10% on weaker-than-expected guidance and results, Seagate down 8% despite an earnings beat, NXP down 8% after reporting revenue of $3.8 billion up 19% year over year, Robinhood down 4% on a double miss, Sensata lower on weak Q4 revenue guidance, Landstar down 3% on a bottom-line miss tied to elevated claim costs, and Teradyne falling despite beating Q3 goals. On the upside: Ultra Clean up 11% on a Q3 beat and upbeat outlook, Manhattan Associates up 11% on an earnings beat, PPG up 7% on a beat-and-raise, and Logitech beating September-quarter views while guiding higher for the holiday period. These are headlines only, so I have the direction and in most cases the stated reason, nothing deeper.

Form 8-K wrapper filings

A long run of Form 8-K items from Investing.com UK carry no article body at all, just the filing notice and the ticker's move: Ultra Clean up 10.21%, Intapp down 8.91%, Senti Biosciences up 6.62%, Sensata up 4.01%, Slide Insurance down 2.37%, Waste Management down 2.16%, Enphase down 2.06%, Zillow Class C down 1.75%, Brightspire up 0.81%, Realty Income down 0.59%, F5 down 0.48%, ONEOK down 0.36%, Envista down 0.34% and STAG down 0.33%. There is nothing in the filings text to explain any of it, and more of the same appear headline-only for Welltower, O-I Glass, Charter, Logitech, Crane, Cooper, Arch Capital and a dozen small banks.

Quarterly misses with figures

Two smaller results were read in full. Renasant posted Q3 EPS of $0.86, eight cents below the $0.94 estimate, with revenue of $272.95 million against a $282.34 million consensus; the stock closed at $41.58, down 4.57% over three months and up 18.73% over twelve. O-I Glass reported a Q3 loss of $0.09 per share versus an expected $0.17 profit, a 26-cent miss, on revenue of $1.62 billion against $1.65 billion expected; shares closed at $6.43, down 46.73% over the past year, and the company had eight negative EPS revisions and no positive ones in the prior 90 days.

Air Canada ahead of results

Air Canada rose 2.0% to C$21.97. The article attributes it to positioning ahead of Q3 results due October 29, a published valuation note calling the stock roughly 7% undervalued at a C$23.09 fair value, and network news including new United Airlines routes, a Montréal-to-Seville service and Air Canada Cargo freighter routes to Panama City, Monterrey and Amsterdam. Scotiabank kept an Outperform rating while trimming its FY2026 EPS forecast; consensus is Moderate Buy with eight of eleven analysts positive and an average target of C$32.73. The TSX rose more than 100 points on base metals strength and Canada-US trade optimism.

Deals, management changes and index backdrop

Deal headlines include EnerSys acquiring Ultralife for $320 million in cash and UMB Financial acquiring El Dorado Savings Bank for $506 million. Langenberg upgraded Boeing on backlog strength, with separate headlines noting Boeing is oversold after a 10.69% drop. People moves run through the feed: Visteon's CFO departing, Eli Lilly reorganising its global operations and its international chief retiring, Elroy Air naming a CFO, and Cardiff Oncology naming an interim CMO. As market backdrop, the quote boxes in the read articles show the S&P 500 at 7,722.67 up 0.60%, the Nasdaq up 1.18%, the Dow up 0.03%, the FTSE 100 down 0.75% with HSBC off 5.42% after a Q3 miss and a $1 billion buyback, Brent around $109.70 and gold futures at $4,073.

The rest is noise

Beyond that, the bulk of the 200 items is filler: TradingView chart posts on gold, bitcoin, Tesla, USD/JPY and various crypto pairs, Nasdaq's automated oversold and moving-average alerts, two items literally titled "Test Funnel", and routine dividend declarations. Nothing there worth your time.

What's in the feed today

This is the unfiltered general wire on 27 October 2026, and most of it is bulk: SEC Form 8-K and Form 4 stubs with no text behind the headline, duplicate Investing.com UK and US versions of the same story, and a long run of TradingView chart posts. A handful of items were read in full and do carry real content, covered below. The common macro backdrop running through them is the Fed's 27-28 October meeting, with rates widely expected to be held, the S&P 500 up around 0.3%, the Nasdaq up about 0.5%, and VIX down roughly 3%. The FTSE 100 was the outlier, down about 1% with HSBC off 6.5% after a Q3 miss and Reckitt down 4.7%.

CoinShares buyback funded by selling its own crypto

CoinShares was the biggest single-stock move in the full-read set, up 5.3% in pre-open trade after its board activated a repurchase programme of up to $40 million. The board said Q3 2026 assets under management were broadly level with Q4 2025 and that buying back stock was a better use of capital than holding the equivalent digital assets, so it liquidated its entire corporate Ethereum treasury, around $16.6 million, and sold half its Solana holding, about $2.7 million, earlier in the month. Buying will be in the open market, possibly under Rule 10b5-1 plans, running until the next AGM expected in Q2 2027. The stock reached $3.99 against a 52-week high of $10.43. Separately the article notes CoinShares Digital Securities filed a new base prospectus for a secured debt programme covering its Bitcoin and Ethereum staking ETPs.

CoreWeave bounces off its 52-week low

CoreWeave rose 4.5% pre-open after announcing new compute capacity in Denmark and the launch of its first Global AI Network Backbone reaching into the Middle East and Asia Pacific. The piece frames this as the first company-specific good news after weeks of selling tied to the debt load, roughly $52 billion in total obligations with bond yields at record distressed levels earlier in the month. Two other supports are cited: Goldman Sachs had upgraded the stock to Buy from Neutral after the selloff, and Nvidia's CEO publicly called CoreWeave financially stronger with a falling cost of capital. The stock had bounced from a 52-week low of $51.24 and remains about 59% below its $141.79 high. Anthropic's IPO filing is mentioned repeatedly across the feed as a broader prop under AI infrastructure names.

Pentair beats and reaffirms

Pentair gained nearly 2.9% pre-open on Q3 adjusted EPS of $1.18 against $1.08 consensus, with revenue of $976 million versus $965.3 million expected. It reaffirmed full-year 2026 adjusted EPS of around $4.70 at the midpoint, above the $4.64 consensus, and guided Q4 to roughly $1.15 with sales growth of 7% to 9%. CEO John Stauch said execution improved with focus and urgency after a difficult second quarter in the Pool segment. The stock had been trading near its 52-week low of $51.13 going in.

CenterPoint raises guidance and its capital plan

CenterPoint reported adjusted EPS of $0.53 against $0.49 expected, with revenue of $2.12 billion exactly in line, and shares rose 1.67% premarket to $41.89. It lifted 2026 adjusted EPS guidance to $1.90-$1.92 and introduced 2027 guidance of $2.07-$2.09, both around 9% growth. The bigger item is a 10-year capital plan raised to $70.7 billion from $66.7 billion, with $1.5 billion of projects pulled into the first five years, which management says supports rate base growth above 14% through 2030. Higher financing costs cost $0.04 a share in the quarter, and the company expects to issue $500-700 million of equity in 2027. CEO Jason Wells pointed to customer-driven growth in Greater Houston as the driver. Adjusted FFO-to-debt was 13.7%, debt-to-equity 2.1, dividend yield 2.33% with 56 straight years of payments. There is a separate headline-only slide-deck item on the same $4 billion capital boost.

PrairieSky Royalty, strong quarter, flat stock

PrairieSky posted adjusted EPS of $0.36 against $0.3176 expected, a 13.4% beat, on revenue of CAD 165 million, of which CAD 153.4 million was royalty production revenue, up 42.3% year on year. Funds from operations rose 42% to CAD 127.9 million. Royalty production averaged 26,936 boe/d, up 5%, with realised oil just over CAD 100 a barrel. Net debt fell CAD 63.6 million in the quarter and CAD 153.5 million year to date. The shares barely moved, at $36.70, near the top of a $24.76-$37.30 range. CEO Andrew Phillips flagged Duvernay growth, with only 22 of 81 wells spudded this year producing at quarter-end, and expects Western Saskatchewan thermal leases to add 4,000-5,000 royalty barrels between 2030 and 2040. Q4 dividend set at CAD 0.265.

Dorman Products, tariff pricing bites the margin

Dorman beat on adjusted EPS at $2.08 versus $2.00 but missed on revenue at $561.7 million against $565.71 million. Sales were a record for the quarter, up about 3%, but EPS fell 21% from $2.62 a year earlier and adjusted gross margin dropped 500 basis points to 39.4%. Management attributed the comparison problem to last year's third quarter benefiting from tariff-driven price increases before the matching costs landed. Full-year guidance was narrowed to 2-3% sales growth and adjusted EPS of $8.50-$8.70, citing soft DIY demand and further tariff-related price cuts in Q4. The stock was essentially unchanged premarket at $124.70. Buybacks have run to a record $112 million in the first nine months.

Stephens trims Simpson Manufacturing

Stephens cut its Simpson Manufacturing price target to $205 from $215, keeping Equal Weight. Q3 beat on volume and operating leverage, with adjusted EBITDA margin of 26.2% against the firm's 23% estimate, but gross margin missed on higher raw material and freight costs. Simpson raised full-year operating margin guidance slightly, though the implied Q4 margin excluding a land sale moves lower on steel and freight costs, with price increases to be announced in coming weeks. Steel is over 50% above last year. Simpson also authorised a $1 billion open-ended buyback. Stephens' stated caution is a softer 2027 housing backdrop.

Form 8-K stubs with no content

A run of 8-K items carries only the filing headline plus a ticker move, no description of what was filed. For the record, the attached moves were Artiva Biotherapeutics down 31.01%, Envoy Medical down 8.15%, IP Strategy Holdings up 7.51%, Esquire Financial up 3.76%, Microbot Medical up 3.31%, GrabAGun up 2.44% and Itron up 0.09%. Nothing in the material explains any of these, so treat them as pointers to the filings rather than news. There is a separate headline saying IP Strategy Holdings regained Nasdaq compliance after a filing delay, which may or may not be the same event.

FX and commodity chart posts

Two FXCM technical posts were read in full and both are short setups: silver at four-hour timeframe with entry at 56.716, stop at 58.619 and target 53.094, and dollar-Swiss franc with entry 0.83360, stop 0.83947, target 0.82529. Both cite price below the Ichimoku cloud. These are third-party chart ideas, not analysis with an underlying event behind them. The feed carries a dozen more of the same type headline-only across gold, Nasdaq, Dow, bitcoin and various crosses.

The rest, headline-only

The remaining bulk is earnings headlines without text: Whirlpool missing and dropping premarket, ADNOC Drilling posting record Q3, Nokian Tyres, IndiaMART, Maruti Suzuki, Teknosa, Inderes, JSW Infrastructure, Daqo narrowing losses, Royal Caribbean raising full-year adjusted EPS guidance to $17.85-$17.95, TransUnion with 12% revenue growth. Several corporate actions: aTyr Pharma doing a 1-for-40 reverse split effective 28 October, WF Holding a 1-for-25, Rentokil a $200 million buyback, Arlo $100 million, Terrestrial Energy $25 million, Invesco a $1.5 billion term loan to repurchase preferred, General Motors moving its listing to Nasdaq on 17 November. A cluster of Cantor Fitzgerald reiterations across Faeth, Flagstar, Merck at $145 and Custom Truck, plus Argus downgrading Abbott on a guidance cut and raising Kinder Morgan. On macro, durable goods rose but missed forecasts, core capital goods rose in September, and Case-Shiller home prices came in at 2.7% year on year against 2.6% expected. On AI, headlines report AMD investing $1 billion in Meta's equity offering as part of a superintelligence infrastructure partnership and Nvidia committing $3 billion to the same Meta offering. A Reuters poll headline puts 2026 average gold at $4,495/oz and silver at $70.30/oz; UBS is reported raising its year-end Brent forecast to $110. None of these were read in full.

Celestica's blowout quarter and 2027 outlook

The biggest thing in the feed is Celestica, which rose nearly 9.7% in after-hours trading on third-quarter results that beat on every line. Adjusted EPS was $3.30 against $1.58 a year earlier, revenue $5.83 billion, up 83% year on year, both above the top of the company's own guidance, with adjusted operating margin at 8.5%, which CEO Rob Mionis called another new high. What really moved it was the forward guide: an initial 2027 outlook of $40.0 billion revenue, $21.50 adjusted EPS and a 9.0% operating margin, implying roughly 90% growth, plus a note that 2028 customer demand forecasts sit meaningfully above the 2027 revenue number. Q4 guidance is $6.275 to $6.575 billion revenue and $3.37 to $3.57 EPS, and full-year 2026 revenue was lifted to $21.0 billion from $20.5 billion with EPS to $11.55. The company also said it intends to start a new normal-course issuer bid buyback in Q4. The article notes the stock had been as much as 45% below its 52-week high of $474.025 going in, and that investor doubts about 800G and 1.6T networking programs versus customer concentration were largely what the print answered. Nothing in the broad market explained the move: the article describes the S&P, Dow and Nasdaq as essentially flat into the close.

Amkor rallies on a mixed print

Amkor Technology rose 5.1% after hours despite missing on both lines. Adjusted EPS was $0.76 against consensus near $0.77 to $0.78, revenue $1.99 billion versus roughly $2.03 to $2.04 billion expected. The offset was profitability: gross margin at 18.3% against 14.3% a year ago, operating income $225 million versus $159 million, with CEO Kevin Engel flagging record revenue in Computing and Automotive & Industrial while Communications stayed a drag. The piece also points to an expanded AI infrastructure partnership with NVIDIA announced days earlier, taking multi-year capacity commitments across Amkor's South Korea and Arizona plants to $3 billion, and notes the stock had already shed about 59% from its 52-week high. A separate headline-only item frames the same move as the stock rising 4% after hours.

Nucor meets consensus and slips

Nucor went the other way, down about 0.5% after hours to $256. Q3 diluted EPS was $5.80 on net sales of $11.25 billion, matching consensus almost exactly, and management guided Q4 earnings to be in line with or modestly above Q3, language the article reads as underwhelming given how the stock had run into the print. It opened at $262.13 and touched $262.86 before the release. Barclays had raised its target to $306 from $295 ahead of the report with an Overweight rating. The article also flags a trailing P/E near double the five-year median and net insider selling over the past year. A headline-only item adds that revenue topped estimates even as EPS met.

Whirlpool and the rest of the earnings tape

Whirlpool is covered only by headlines here, which say it missed by $1.25 with revenue short of estimates and the stock tumbled 8% on weak guidance and the Q3 miss. The rest of the earnings headlines split both ways: misses at Greenbrier (by $0.43), Sun (by $0.12), Capital Bancorp (by $0.03) and Alexandria Real Estate (by $3.70, though revenue topped), in-line results with soft revenue at Custom Truck One Source, and beats at Flexsteel, Hawkins (shares up 12%), Agilysys (which fell anyway despite raised guidance), Rambus (beat but fell on guidance), Brixmor, Northwest Bancshares, Simpson Manufacturing, Dorman and CB Financial. Cadence Design Systems is headlined as a beat-and-raise with the stock surging. JetBlue headlines conflict in tone: one says shares jumped on Q3 results and the 2027 outlook, another says it posted a wider loss on surging fuel costs. Public Storage missed Q3 estimates but raised its 2026 outlook.

Customers Bancorp at a 52-week low

Customers Bancorp hit a 52-week low of $20.45, on a 6.24% dividend yield, a 9.61 P/E and a beta of 1.53, with the one-year change still positive at 2.39%. The article gives no reason for the low and in fact recaps a strong Q3: EPS $2.25, up 10% sequentially, ROE 14%, net interest income over $208 million (up 8%), loans up nearly $500 million to $18.5 billion, deposits up 4% to a record $22.6 billion, margin at 3.19% with a September run rate near 3.25%, non-interest expense down to $113.4 million, and full-year guidance raised to 12%-plus loan and 9%-plus deposit growth. The bank also claimed AI tools cut loan underwriting cycle time by 95% and commercial deposit onboarding by over 90%.

Mostly filings and chart posts

A large share of the 200 items is regulatory boilerplate with no content behind the headline: Form 8-K notices for D.R. Horton, Nasdaq, Celestica, Amkor, Rambus, Whirlpool, AZZ, Clearwater Paper, C&F Financial, H2O America, NewHydrogen, Applied Materials, Cincinnati Financial, the three Gladstone entities and others, Form 144s for Euroseas and Symbotic, a run of Form 4 director filings at the New York Times, and routine insider sale disclosures at Goldman Sachs, MIAX, First Interstate and Beacon Financial. Alongside that sits a block of Nasdaq screen-generated "crosses critical technical indicator" and oversold alerts, and a long tail of TradingView chart ideas on gold, EURUSD, DXY, bitcoin, ETH and the indices. None of it carries substance worth pulling out.

Corporate and sector odds and ends

A few headline-only items are worth knowing exist: Intel is to acquire quantum computing software firm Classiq; Applied Materials is raising its Besi stake to roughly 20%; Bank of America, Blackstone, Citi and Morgan Stanley are reported arranging $63 billion of AI financing; Ben & Jerry's is said by the WSJ to be exploring a deal with a KKR executive to separate the brand from its owner; Truelink Capital is to acquire Johnson Controls' intrusion unit; and a US judge declined to block Eli Lilly's weight-loss drug ads, ruling against Novo Nordisk. On commodities, headlines report sugar, cocoa and coffee all falling on a decline in the Brazilian real, and natural gas at a new six-and-a-quarter-month low on warm forecasts. Two Reuters/Ipsos poll headlines carry Trump approval rising to 32% from a record low a week earlier, and Democrats leading Republicans 47% to 36% on the generic congressional ballot.

US — major movers

Your earnings